Inversago Pharma Employee Directory

Biotechnology ResearchQuebec, Canada2-10 Employees

Inversago Pharma is a privately held biotech company headquartered in Montreal, Quebec, focused on developing therapies for metabolic and fibrotic diseases. Operating at a clinical-stage level, the company specializes in CB1 blockade through peripherally acting CB1 inverse agonists, aiming to offer treatment options for conditions such as diabetic kidney disease, diabetes, non-alcoholic steatohepatitis, obesity-related complications, hypertriglyceridemia, and fibrotic diseases including progressive fibrosis of interstitial lung disease and idiopathic pulmonary fibrosis. The firm targets pharmaceutical and medical research partners seeking novel approaches to metabolic and fibrotic indications, with its work centered on advancing first-in-class therapies to address unmet medical needs. Inversago is part of the biotechnology research landscape in Canada and has been involved in notable strategic events in the industry, including interactions that have influenced its development trajectory.

Sign up for free to view info

Company overview Email format